Get the Stockscreener App
0.2872
0.77%
0.0022
Pre-market:
.28
-0.0072
-2.51%
Oragenics Inc stock is traded at $0.2872, with a volume of 271.72K.
It is up +0.77% in the last 24 hours and down -2.31% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$0.285
Open:
$0.29
24h Volume:
271.72K
Relative Volume:
0.06
Market Cap:
$3.94M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.0336
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
+3.57%
1M Performance:
-2.31%
6M Performance:
-45.73%
1Y Performance:
-80.06%
1-Day Range:
$0.2801
$0.2941
1-Week Range:
$0.2622
$0.31
52-Week Range:
$0.25
$3.43
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
0.2872 | 3.94M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Oragenics Inc Stock (OGEN) Latest News
StockNews.com Begins Coverage on Oragenics (NYSE:OGEN) - Defense World
The Oragenics Inc (OGEN) Stock Is Headed for a Correction - US Post News
Digital Risk Inc. Launches Digital Footprint Exposure Assessment Tool to Combat Human Cybersecurity Risks - The Manila Times
Oragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Australia for Mild Traumatic Brain Injury - Nasdaq
Oragenics, Inc. Submits Investigator’s Brochure for Phase - GlobeNewswire
Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain - EIN News
Oragenics (NYSE:OGEN) Coverage Initiated by Analysts at StockNews.com - Defense World
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment - The Manila Times
Heritage Distilling Co. Cocoa Bomb Chocolate Whiskey Named 'Best Flavored Whiskey” in the United States at Whisky Magazine's World Whiskies Awards - The Manila Times
Oragenics, Inc. to Present Concussion Treatment Advancements at Emergencies in Medicine Conference - Nasdaq
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, - GlobeNewswire
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health - The Manila Times
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab - The Manila Times
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, - GlobeNewswire
5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail
Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World
Oragenics, Inc. Announces Partnership with BRAINBox - GlobeNewswire
Oragenics Partners With BRAINBox To Develop Intranasal Therapy For Concussion Treatment - Nasdaq
Irobot Corp (IRBT) Stock: From Low to High in 52 Weeks - The InvestChronicle
Adversity is less terrifying than hope: Oragenics Inc (OGEN) - SETE News
Alkeus Pharmaceuticals Announces Two Presentations of Oral Gildeuretinol Data During the 48th Annual Meeting of the Macula Society Being Held February 12-15, 2025 - The Manila Times
Oragenics, Inc. Partners with BRAINBox Solutions to Develop Innovative Intranasal Therapy for Concussion Management - Nasdaq
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment - Yahoo Finance
Press Telegram - Financial Content
Oragenics Inc (AMEX:OGEN): It’s all about numbers this morning - US Post News
Closing Strong: Oragenics Inc (OGEN) Ends at 0.26, Down -9.26 from Last Close - The Dwinnex
Market Recap: Lexeo Therapeutics Inc (LXEO)’s Negative Momentum, Closing at 4.95 - The Dwinnex
Market Watch: Outset Medical Inc (OM)’s Noteworthy Gain, Closing at 0.81 - The Dwinnex
Oragenics, Inc. Chief Medical Officer to Speak at Brain Health SummitOn February 5, 2025, Oragenics, Inc. (NYSE American: OGEN) revealed through a press release that its Chief Medical Officer, James P. Kelly, MA, MD, FAAN, FANA, will be a prominent p - Defense World
Virpax Pharmaceuticals Appoints Charn Deol as Independent DirectorVirpax Pharmaceuticals, Inc. (NASDAQ:VRPX) announced on February 5, 2025, the appointment of Mr. Charn Deol as an independent director of the Company, effective immediately. Mr. D - Defense World
There is no way Arrowhead Pharmaceuticals Inc (ARWR) can keep these numbers up - SETE News
Views of Wall Street’s Leading Experts on Oragenics Inc - SETE News
Power Nickel's (TSX.V: PNPN) Hole Delivers "BIG"- Gold Terra - openPR
Power Nickel’s (TSX.V: PNPN) Hole Delivers “BIG”- Gold Terra (TSX.V: YGT) Developments and Exploration Progress Reported – More Stocks Inside! | FinancialContent Business Page - Financial Content
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
OGEN’s valuation metrics: A comprehensive analysis - US Post News
Unum Group to Present at the 2025 UBS Financial Services Conference - Yahoo Finance UK
In the Green: Oragenics Inc (OGEN) Closes at 0.28, Up/Down -2.34 from Previous Day - The Dwinnex
Closing Bell Recap: Merck & Co Inc (MRK) Ends at 90.74, Reflecting a -9.07 Downturn - The Dwinnex
Market Insights: 4D Molecular Therapeutics Inc (FDMT)’s Notable Drop of -0.17, Closing at 5.92 - The Dwinnex
Post-Trade Analysis: Charter Communications Inc (CHTR) Slides -0.36, Closing at 340.26 - The Dwinnex
US Stocks Mixed; Walt Disney Posts Upbeat Earnings - Benzinga
United Micro Electronics ADR [UMC] Investment Guide: What You Need to Know - Knox Daily
Oragenics Inc (OGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily
The Potential Rise in the Price of Dolby Laboratories Inc (DLB) following insiders activity - Knox Daily
Oragenics Inc Inc. (OGEN) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
PCSO Lotto Results | February 5, 2025 - The Manila Times
Oragenics, Inc. CMO James P. Kelly to Speak at 12th Annual Brain Health Summit During Super Bowl Weekend - Nasdaq
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025 - yourbigsky.com
Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News
Nisa Investment Advisors LLC Sells 121,826 Shares of Hudson Pacific Properties, Inc. (NYSE:HPP) - Defense World
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):